Literature DB >> 10788807

Operation for partial atrioventricular septal defect: a forty-year review.

E K El-Najdawi1, D J Driscoll, F J Puga, J A Dearani, B E Spotts, D W Mahoney, G K Danielson.   

Abstract

BACKGROUND: We describe the long-term outcome of repair of partial atrioventricular septal defect by determining the rates of survival, reoperation, and occurrence of left atrioventricular valve regurgitation, left atrioventricular valve stenosis, left ventricular outflow tract obstruction, and arrhythmia.
METHODS: We studied 334 patients who underwent repair of partial atrioventricular septal defect before 1995.
RESULTS: The 30-day and 5-, 10-, 20-, and 40-year survival were 98%, 94%, 93%, 87%, and 76%, respectively. Closure of the left atrioventricular valve cleft (P =. 03) and age less than 20 years at operation (P <.001) were associated with better survival. Reoperation was performed for 38 patients (11%). Repair of residual/recurrent left atrioventricular valve regurgitation or stenosis was the most common reason for reoperation. Left ventricular outflow tract obstruction occurred in 36 patients, and 7 patients underwent reoperation to relieve this obstruction. Supraventricular arrhythmias were observed in 58 patients (16%) after the operation. Supraventricular arrhythmias increased with increasing age at primary operation (P =.001). Complete atrioventricular block occurred in 9 patients (3%). Permanent pacemakers were implanted in 11 patients.
CONCLUSIONS: Long-term survival after repair of partial atrioventricular septal defect is good. It is important to close the cleft in the left atrioventricular valve. Reoperation for persistent or recurrent left atrioventricular valve malfunction and relief of left ventricular outflow tract obstruction is necessary in approximately 11% of patients.

Entities:  

Mesh:

Year:  2000        PMID: 10788807     DOI: 10.1016/S0022-5223(00)70082-1

Source DB:  PubMed          Journal:  J Thorac Cardiovasc Surg        ISSN: 0022-5223            Impact factor:   5.209


  8 in total

Review 1.  Atrioventricular septal defect: from fetus to adult.

Authors:  Brian Craig
Journal:  Heart       Date:  2006-12       Impact factor: 5.994

2.  "Baby Heart Project": the Italian project for accreditation and quality management in pediatric cardiology and cardiac surgery.

Authors:  Sonia B Albanese; Lucio V Zannini; Gianluigi Perri; Giancarlo Crupi; Bruno Turinetto; Giacomo Pongiglione
Journal:  Pediatr Cardiol       Date:  2014-06-01       Impact factor: 1.655

Review 3.  Atrial septal defect: spectrum of care.

Authors:  R Kharouf; D M Luxenberg; O Khalid; R Abdulla
Journal:  Pediatr Cardiol       Date:  2007-10-23       Impact factor: 1.655

4.  Effectiveness of balloon valvuloplasty for palliation of mitral stenosis after repair of atrioventricular canal defects.

Authors:  Joshua D Robinson; Gerald R Marx; Pedro J Del Nido; James E Lock; Doff B McElhinney
Journal:  Am J Cardiol       Date:  2009-05-04       Impact factor: 2.778

5.  Complete versus partial atrioventricular canal: equal risks of repair in the modern era.

Authors:  Jeffrey T Cope; Gregory D Fraser; Peter C Kouretas; Irving L Kron
Journal:  Ann Surg       Date:  2002-10       Impact factor: 12.969

Review 6.  Atrial tachyarrhythmia in adult congenital heart disease.

Authors:  Arsha Karbassi; Krishnakumar Nair; Louise Harris; Rachel M Wald; S Lucy Roche
Journal:  World J Cardiol       Date:  2017-06-26

7.  Repair of partial atrioventricular canal defect in adult patients: two-year follow-up outcomes of a retrospective study.

Authors:  Lingyun Song; Yunfei Ling; Qi An
Journal:  J Cardiothorac Surg       Date:  2019-06-11       Impact factor: 1.637

8.  Challenges in the Surgical Treatment of Atrioventricular Septal Defect in Children With and Without Down Syndrome in Romania-A Developing Country.

Authors:  Ioana-Cristina Olariu; Anca Popoiu; Andrada-Mara Ardelean; Raluca Isac; Ruxandra Maria Steflea; Tudor Olariu; Adela Chirita-Emandi; Ramona Stroescu; Mihai Gafencu; Gabriela Doros
Journal:  Front Pediatr       Date:  2021-07-07       Impact factor: 3.418

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.